These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9872186)

  • 1. Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged.
    Wentzien TH; O'Reilly RA; Kearns PJ
    Chest; 1998 Dec; 114(6):1546-50. PubMed ID: 9872186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the anticoagulant effects of warfarin by vitamin K1.
    Hirsh J
    Chest; 1998 Dec; 114(6):1505-8. PubMed ID: 9872176
    [No Abstract]   [Full Text] [Related]  

  • 3. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary reversal of anticoagulation using oral vitamin K.
    White RH; Minton SM; Andya MD; Hutchinson R
    J Thromb Thrombolysis; 2000 Oct; 10(2):149-53. PubMed ID: 11005937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.
    Fan J; Armitstead JA; Adams AG; Davis GA
    Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of excessive anticoagulation with low-dose oral vitamin K1.
    Weibert RT; Le DT; Kayser SR; Rapaport SI
    Ann Intern Med; 1997 Jun; 126(12):959-62. PubMed ID: 9182473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective and prospective analyses of the treatment of overanticoagulated patients.
    Duong TM; Plowman BK; Morreale AP; Janetzky K
    Pharmacotherapy; 1998; 18(6):1264-70. PubMed ID: 9855325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
    Bian C; Qi X; Li L; Zhao J; Liu X
    Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin Poisoning with Delayed Rebound Toxicity.
    Berling I; Mostafa A; Grice JE; Roberts MS; Isbister GK
    J Emerg Med; 2017 Feb; 52(2):194-196. PubMed ID: 27838137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
    Sconce EA; Kamali F
    Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.
    Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA
    J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review.
    Fugate SE; Nichols CM; Cudd LA
    Pharmacotherapy; 2004 Sep; 24(9):1213-20. PubMed ID: 15460182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.
    Watson HG; Baglin T; Laidlaw SL; Makris M; Preston FE
    Br J Haematol; 2001 Oct; 115(1):145-9. PubMed ID: 11722425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
    Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
    Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.